HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Today’s Beauty Market: From Sampling Campaigns To Surgery Complements

This article was originally published in The Rose Sheet

Executive Summary

Success in today's beauty market may come easier to firms that embrace innovative sampling, address problems above and below the neck, take up a new attitude about sun care and launch personal-care products that complement surgical procedures, according to industry veteran Alisa Marie Beyer

You may also be interested in...



Plastic surgery popularity gains

Surgical and non-surgical activity rose 27% in 2007, American Academy of Facial Plastic and Reconstructive Surgery reports. AAFPRS members say men are increasingly willing to go under the knife, with 30% of the increase attributed to men and 26% to women. However, women still make up 81% of all surgical procedures and 82% of non-surgical procedures performed. Interest in plastic surgery also crosses ethnic lines: African-American cosmetic surgical patients grew by 40% over the past eight years, compared with a 19% increase among Hispanics, a 7% jump among Caucasians, and an 8% decrease among Asian-American patients. According to The Benchmarking Company, heightened interest in plastic surgery has opened up the market for topical skin-care products that complement aesthetic procedures (1"The Rose Sheet" July 30, 2007, p. 5). In particular, rise of non-invasive surgical options, like Botox or hyaluronic acid injections, bodes well for results-driven personal-care products, according to Datamonitor (2"The Rose Sheet" Feb. 25, 2008, p. 4)...

Plastic surgery popularity gains

Surgical and non-surgical activity rose 27% in 2007, American Academy of Facial Plastic and Reconstructive Surgery reports. AAFPRS members say men are increasingly willing to go under the knife, with 30% of the increase attributed to men and 26% to women. However, women still make up 81% of all surgical procedures and 82% of non-surgical procedures performed. Interest in plastic surgery also crosses ethnic lines: African-American cosmetic surgical patients grew by 40% over the past eight years, compared with a 19% increase among Hispanics, a 7% jump among Caucasians, and an 8% decrease among Asian-American patients. According to The Benchmarking Company, heightened interest in plastic surgery has opened up the market for topical skin-care products that complement aesthetic procedures (1"The Rose Sheet" July 30, 2007, p. 5). In particular, rise of non-invasive surgical options, like Botox or hyaluronic acid injections, bodes well for results-driven personal-care products, according to Datamonitor (2"The Rose Sheet" Feb. 25, 2008, p. 4)...

Reliant Launches Cosmeceutical Line To Complement Fraxel Laser Treatment

Reliant Technologies is introducing a home-use cosmeceutical skin-care line to complement its Fraxel skin rejuvenation laser treatment, the firm announced Sept. 8 at the Medical Spa and Resort Expo and Conference in New York

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014884

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel